Hepatitis C Virus Therapy
Study findings from Erasmus University broaden understanding of hepatitis C virus therapy
Published in Hepatitis Weekly, November 26th, 2007
Scientists discuss in 'Gamma-glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-alpha-2b in chronic hepatitis C non-responders' new findings in hepatitis C virus. "High-dose peginterferon-alpha (PegIFN-alpha) induction and prolongation of therapy may be an option to improve sustained virological response (SVR) rates among hepatitis C virus (HCV) non-responders, although a higher and a longer dosing of PegIFN-alpha may intensify side effects We randomized 53 patients, who previously failed with standard IFN-alpha±ribavirin, to a high-dose induction and an extended regimen with PegIFN-alpha-2b [3.0...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-11-26)
More Articles from Hepatitis Weekly
- Hepatitis C Virus
Interferon does not slow or stop hepatitis C from worsening, study finds - Hepatitis A Virus
New findings from L.M. Villar and co-authors describe advances in hepatitis A virus - Hepatitis B Virus
Data from T. Vassiliadis et al provide new insights into hepatitis B virus - Hepatitis B Virus
Investigators at Chinese University of Hong Kong target hepatitis B virus - Hepatitis B Virus
Scientists at Zhengzhou University report research in hepatitis B virus - Hepatitis B Virus
Study results from University of Washington provide new insights into hepatitis B virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
